Plasma contacting with liquid provides many charged particles and reactive species into the liquid. The difficulty in controlling or selecting each specific species has significantly limited its applications in industry. Here, we present a study on using voltage polarity to regulate the type of charged particles absorbing from plasma into liquid. Detailed understanding of the processes at the plasma-liquid interface, electrolysis due to switching in voltage polarity was investigated via a visual pH observation, measuring the concentration of H2O2 and solvated electrons. The results indicated that changing in voltage polarity strongly affects the plasma properties, chemical properties, and electrolysis process in liquid, and further in the types of reducing species for gold nanoparticle synthesis. The results also showed using a suitable frequency could improve the efficiency of absorption of H2O2from plasma into the bulk liquid and the yield in the production of gold nanoparticles. The results provide a way to select desired species from plasma into the liquid for a distinct purpose and accompanying other properties in the system of plasma contacting with liquid.

Nonspecific tumoricidal effectors, called lymphokine-activated killer (LAK) cells, can be induced from the tumor-bearer's spleen in vitro. The adoptive transfer of such LAK cells to a patient with unresectable hepatoma was performed in this study. About 2.4 X 10(9) LAK cells generated from the autologous spleen were adoptively transferred to the patient via hepatic arterial catheter. Signs of toxicity encountered with LAK cell infusions comprised chills and fever only. Chemical studies of hepatic, renal, and hematologic parameters were normal; pulmonary function studies revealed no changes after infusion. With the transfer of LAK cells, serum alpha-fetoprotein (AFP) levels were markedly decreased and ascitic fluid retention was transiently reduced. Though the therapeutic effect was transient, these trials offered hope for a new therapeutic approach to unresectable hepatoma. Further, the availability of large amounts of recombinant interleukin-2 (rIL-2) may now make widespread use of this approach possible.

No abstract